PPARA and metabolic dysfunction-associated steatohepatitis: Also, Sandoval-Rodriguez et al. had previously reported that protein expression of Ppara is diminished in a mouse MAFLD/NASH model and restored to similar levels than CVD in animals treated with PFD51.